The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO GI 2025 | Blood-based tests could improve colorectal cancer screening rates
Aasma Shaukat, MD, MPH, NYU Grossman School of Medicine, New York, NY, comments on the potential of blood-based tests for colorectal cancer screening, highlighting their potential to increase screening rates and provide primary care providers with another option. Dr Shaukat emphasizes the importance of ensuring universal access to these tests, regardless of socioeconomic status, and making them available at various locations for convenient blood draws. This interview took place at the ASCO GI Cancers Symposium 2025 in San Francisco, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
